Tyzeka is a new oral antiviral for chronic hepatitis B

Tyzeka is a new oral antiviral for chronic hepatitis B.

It's an alternative to using lamivudine (Epivir-HBV)...adefovir (Hepsera)...entecavir (Baraclude)...or interferons (Pegasys, etc).

Tyzeka (telbivudine) is well-tolerated like lamivudine...but it's more effective at suppressing the hepatitis B virus.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote